Malignant Gastric Neoplasm — Trials

Malignant Gastric Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 652
Recruiting: 352
Ph III recruiting: 49
Growth YoY: +15.1%
Industry share: 26%
Top sponsor: Fudan University
Termination share: 26.2%
Trials / 1,000 deaths: 59.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (232)

clinicaltrialsPublishedShowing 101–106 of 106 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00195572	Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer	completed	Phase 3	200	Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY	1	Aug 13, 2009	clinicaltrials
NCT00738478	Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients	completed	Phase 3	180	Wakayama Medical UniversityOTHER	1	Feb 18, 2009	clinicaltrials